Skip to Content
Severe eczema holding you back? Find the right treatment

Eflornithine topical Pregnancy and Breastfeeding Warnings

Eflornithine topical is also known as: Vaniqa

Eflornithine topical Pregnancy Warnings

Eflornithine topical has been assigned to pregnancy category C by the FDA. Some animal studies have revealed evidence of teratogenicity when oral ingestion from topical application was not prevented. There are no controlled data in human pregnancies. The manufacturer recommends that serious consideration be given to not using eflornithine topical during pregnancy.

The manufacturer has reported that 19 pregnancies occurred while using eflornithine topical during clinical trials. Of these, there were 9 healthy infants, 4 spontaneous abortions, 5 induced/elective abortions, and 1 birth defect (Down's Syndrome to a 35-year-old).

See references

Eflornithine topical Breastfeeding Warnings

There are no data on the excretion of eflornithine topical into human milk.

See references

References for pregnancy information

  1. "Product Information. Vaniqa (eflornithine topical)" Bristol-Myers Squibb, Princeton, NJ.

References for breastfeeding information

  1. "Product Information. Vaniqa (eflornithine topical)" Bristol-Myers Squibb, Princeton, NJ.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.